Carica Pharma

Company Description

Our corporate venture was first launched with initial business capital of US$10 Million - US$50 Million. Based on our vast industrial experience with Ceftriaxone Injection we came a long way from when Carica Pharma LLC was first introduced in market, back in 2008. The reason we excel in delivering best quality Ceftriaxone Injection is our high-end facility in NEW DELHI, , India, equipped with technologically advanced equipment and skilled workforce. To keep durability intact we only source raw material from trusted resources, enabling us to deliver products that meet international standards. In the long run, our quality supplies led us to capture Indonesia,South Korea,Latvia,Taiwan,United Kingdom export market share, generating annual revenue across Approx 0.5 Billion US Dollar.The reason our products attract buyers is our strong reputation as a leading Ceftriaxone Injection Supplier and Manufacturer, operating as a legal entity owing to Agency. We boast a successful export history of 12 Years with US$5 Million - US$10 Million export value.